Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Phytohealth Corp (4108)

Taiwan
Currency in TWD
Disclaimer
20.80
+0.30(+1.46%)
Closed
Fair Value
Unlock Value
Day's Range
20.5021.15
52 wk Range
18.7525.25
Bid/Ask
25.05 / 25.10
Prev. Close
20.5
Open
20.5
Day's Range
20.5-21.15
52 wk Range
18.75-25.25
Volume
592,535
Average Volume (3m)
376,352
1-Year Change
9.33%
Shares Outstanding
198,618,879
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about 4108?
Vote to see community's results!
or

Phytohealth Corp Company Profile

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. The company operates in three segments: Pharmaceutical Drugs and Dietary Supplement, Medical Diagnostic Products, and Precision Medical Equipment. The Pharmaceutical Drugs and Dietary Supplement segment manufactures and sells Chinese medicine and new pharmaceutical products. The Medical Diagnostic Products segment develops and sells smart medical imaging diagnostic products device. The Precision Medical Equipment segment engages in the research and development, manufacturing, and sale of ultrasonic probes. The company’s products under development include PHN031, which has completed Phase II clinical trials for the treatment of osteoporosis; and PHN033, which has completed Phase II clinical trials for the treatment of diabetic nephropathy. It is also developing PHN016 that is in Phase II clinical trials for the treatment of cancer; and PHN017 for the treatment of severe infection-induced cytokine storm and is in phase I trial. In addition, the company offers PG2 Lyophilized injection for the treatment of cancer related fatigue; and capsules. It has collaboration agreement with Indena S.P.A for the development of botanical extracts. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Employees
84
Market
Taiwan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.